title: Plasma bacterial and mitochondrial DNA distinguish bacterial sepsis from sterile systemic inflammatory response syndrome and quantify inflammatory tissue injury in nonhuman primates.
abstract: Systemic inflammatory response syndrome (SIRS) is a fundamental host response common to bacterial infection and sterile tissue injury. Systemic inflammatory response syndrome can cause organ dysfunction and death, but its mechanisms are incompletely understood. Moreover, SIRS can progress to organ failure or death despite being sterile or after control of the inciting infection. Biomarkers discriminating between sepsis, sterile SIRS, and postinfective SIRS would therefore help direct care. Circulating mitochondrial DNA (mtDNA) is a damage-associated molecular pattern reflecting cellular injury. Circulating bacterial 16S DNA (bDNA) is a pathogen-associated pattern (PAMP) reflecting ongoing infection. We developed quantitative polymerase chain reaction assays to quantify these markers, and predicting their plasma levels might help distinguish sterile injury from infection. To study these events in primates, we assayed banked serum from Papio baboons that had undergone a brief challenge of intravenous Bacillus anthracis delta Sterne (modified to remove toxins) followed by antibiotics (anthrax) that causes organ failure and death. To investigate the progression of sepsis to "severe" sepsis and death, we studied animals where anthrax was pretreated with drotrecogin alfa (activated protein C), which attenuates sepsis in baboons. We also contrasted lethal anthrax bacteremia against nonlethal E. coli bacteremia and against sterile tissue injury from Shiga-like toxin 1. Bacterial DNA and mtDNA levels in timed samples were correlated with blood culture results and assays of organ function. Sterile injury by Shiga-like toxin 1 increased mtDNA, but bDNA was undetectable: consistent with the absence of infection. The bacterial challenges caused parallel early bDNA and mtDNA increases, but bDNA detected pathogens even after bacteria were undetectable by culture. Sublethal E. coli challenge only caused transient rises in mtDNA consistent with a self-limited injury. In lethal anthrax challenge (n = 4), bDNA increased transiently, but mtDNA levels remained elevated until death, consistent with persistent septic tissue damage after bacterial clearance. Critically, activated protein C pretreatment (n = 4) allowed mtDNA levels to decay after bacterial clearance with sparing of organ function and survival. In summary, host tissue injury correlates with mtDNA whether infective or sterile. Mitochondrial DNA and bDNA polymerase chain reactions can quantify tissue injury incurred by septic or sterile mechanisms and suggest the source of SIRS of unknown origin.
authors.affiliation: Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
authors.forename: Tolga
authors.initials: T
authors.lastname: Sursal
authors.forename: Deborah J
authors.initials: DJ
authors.lastname: Stearns-Kurosawa
authors.forename: Kiyoshi
authors.initials: K
authors.lastname: Itagaki
authors.forename: Sun-Young
authors.initials: SY
authors.lastname: Oh
authors.forename: Shiqin
authors.initials: S
authors.lastname: Sun
authors.forename: Shinichiro
authors.initials: S
authors.lastname: Kurosawa
authors.forename: Carl J
authors.initials: CJ
authors.lastname: Hauser
mesh_terms: D000818:Animals; D000881:Anthrax / Q000175:diagnosis* / Q000188:drug therapy; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000175:diagnosis* / Q000188:drug therapy; D015415:Biomarkers / Q000097:blood; D004269:DNA, Bacterial / Q000097:blood*; D004272:DNA, Mitochondrial / Q000097:blood*; D003937:Diagnosis, Differential; D018450:Disease Progression; D004211:Disseminated Intravascular Coagulation / Q000175:diagnosis / Q000382:microbiology; D004927:Escherichia coli Infections / Q000175:diagnosis; D009102:Multiple Organ Failure / Q000175:diagnosis / Q000382:microbiology; D010215:Papio; D011486:Protein C / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D016019:Survival Analysis; D018746:Systemic Inflammatory Response Syndrome / Q000175:diagnosis* / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents; D015415:Biomarkers; D004269:DNA, Bacterial; D004272:DNA, Mitochondrial; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated